Medical and surgical treatment outcomes in patients with chronic rhinosinusitis and immunodeficiency: a systematic review.
chronic rhinosinusitis
endoscopic sinus surgery
immunoglobulin replacement therapy
primary immunodeficiency
secondary immunodeficiency
Journal
International forum of allergy & rhinology
ISSN: 2042-6984
Titre abrégé: Int Forum Allergy Rhinol
Pays: United States
ID NLM: 101550261
Informations de publication
Date de publication:
02 2021
02 2021
Historique:
received:
08
03
2020
revised:
24
05
2020
accepted:
05
06
2020
pubmed:
16
7
2020
medline:
30
9
2021
entrez:
16
7
2020
Statut:
ppublish
Résumé
Immunodeficiency is a risk factor for recalcitrant chronic rhinosinusitis (CRS). Currently, there is no consensus on effective treatment modalities for immunodeficient CRS patients. This review aims to evaluate the existing evidence on the treatment outcomes and its limitations in patients with CRS and immunodeficiency. MEDLINE, Embase, and the Cochrane Central Register of Controlled Trials (CENTRAL) were searched from inception to April 2019 for studies reporting measurable medical or surgical treatment outcomes for adult patients with CRS and underlying primary or secondary immunodeficiency. Of the 2459 articles screened, 13 studies met the inclusion criteria: 2 prospective double-blind placebo-controlled trials, 2 prospective case-control studies, 2 prospective cohort studies, and 7 case series. The high degree of study heterogeneity precluded a meta-analysis. Antibiotic monotherapy was not linked with significant improvement in clinical, radiographic, or endoscopic outcomes. Immunoglobulin replacement therapy may potentially reduce the frequency of acute or chronic sinusitis in patients with primary immunodeficiency (PID) but may not improve their sinonasal symptoms. Outcomes from endoscopic sinus surgery (ESS) were reported in 8 studies, which found that surgery was linked with improvement in symptoms, disease-specific quality of life, endoscopy scores, and radiographic scores. The average reported ESS revision rate was 14%. Patients with CRS and immunodeficiency likely benefit from ESS based on the available evidence. Data supporting medical therapy in this targeted population is limited overall, but there may be a potential role for immunoglobulin therapy in patients with PID and CRS.
Sections du résumé
BACKGROUND
Immunodeficiency is a risk factor for recalcitrant chronic rhinosinusitis (CRS). Currently, there is no consensus on effective treatment modalities for immunodeficient CRS patients. This review aims to evaluate the existing evidence on the treatment outcomes and its limitations in patients with CRS and immunodeficiency.
METHODS
MEDLINE, Embase, and the Cochrane Central Register of Controlled Trials (CENTRAL) were searched from inception to April 2019 for studies reporting measurable medical or surgical treatment outcomes for adult patients with CRS and underlying primary or secondary immunodeficiency.
RESULTS
Of the 2459 articles screened, 13 studies met the inclusion criteria: 2 prospective double-blind placebo-controlled trials, 2 prospective case-control studies, 2 prospective cohort studies, and 7 case series. The high degree of study heterogeneity precluded a meta-analysis. Antibiotic monotherapy was not linked with significant improvement in clinical, radiographic, or endoscopic outcomes. Immunoglobulin replacement therapy may potentially reduce the frequency of acute or chronic sinusitis in patients with primary immunodeficiency (PID) but may not improve their sinonasal symptoms. Outcomes from endoscopic sinus surgery (ESS) were reported in 8 studies, which found that surgery was linked with improvement in symptoms, disease-specific quality of life, endoscopy scores, and radiographic scores. The average reported ESS revision rate was 14%.
CONCLUSION
Patients with CRS and immunodeficiency likely benefit from ESS based on the available evidence. Data supporting medical therapy in this targeted population is limited overall, but there may be a potential role for immunoglobulin therapy in patients with PID and CRS.
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Systematic Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
162-173Informations de copyright
© 2020 ARS-AAOA, LLC.
Références
Orlandi RR, Kingdom TT, Hwang PH, et al. International Consensus Statement on Allergy and Rhinology: Rhinosinusitis. Int Forum Allergy Rhinol. 2016;6(Suppl 1):S22-S209.
Picard C, Bobby Gaspar H, Al-Herz W, et al. International Union of Immunological Societies: 2017 Primary Immunodeficiency Diseases Committee Report on Inborn Errors of Immunity. J Clin Immunol. 2018;38:96-128.
Bonilla FA, Khan DA, Ballas ZK, et al. Practice parameter for the diagnosis and management of primary immunodeficiency. J Allergy Clin Immunol. 2015;136:1186-1205.e78.
Khalid AN, Mace JC, Smith TL. Outcomes of sinus surgery in ambulatory patients with immune dysfunction. Am J Rhinol Allergy. 2010;24:230-233.
Patel ZM. Practice patterns regarding noninvasive rhinosinusitis in the immunosuppressed patient population. Allergy Rhinol (Providence). 2013;4:e151-e154.
Stevens WW, Peters AT. Immunodeficiency in chronic sinusitis: recognition and treatment. Am J Rhinol Allergy. 2015;29:115-118.
Quinti I, Soresina A, Spadaro G, et al. Long-term follow-up and outcome of a large cohort of patients with common variable immunodeficiency. J Clin Immunol. 2007;27:308-316.
Angulo-Pérez G, Vivar-Acevedo E, Vargas-Aguayo A, López-Rocha E. Prevalence, location and tomographic severity of chronic rhinosinusitis in adult patients with common variable immunodeficiency. Rev Alerg Mex. 2015;62:15-21.
Plebani A, Soresina A, Rondelli R, et al. Clinical, immunological, and molecular analysis in a large cohort of patients with X-linked agammaglobulinemia: an Italian multicenter study. Clin Immunol. 2002;104:221-230.
Moin M, Aghamohammadi A, Farhoudi A, et al. X-linked agammaglobulinemia: a survey of 33 Iranian patients. Immunol Invest. 2004;33:81-89.
Ballow M. Primary immunodeficiency disorders: antibody deficiency. J Allergy Clin Immunol. 2002;109:581-591.
Cunningham-Rundles C. Physiology of IgA and IgA deficiency. J Clin Immunol. 2001;21:303-309.
Chee L, Graham SM, Carothers DG, Ballas ZK. Immune dysfunction in refractory sinusitis in a tertiary care setting. Laryngoscope. 2001;11:233-235.
Hoover GE, Newman LJ, Platts-Mills TA, et al. Chronic sinusitis: risk factors for extensive disease. J Allergy Clin Immunol. 1997;100:185-191.
Jorgensen GH, Gardulf A, Sigurdsson MI, et al. Clinical symptoms in adults with selective IgA deficiency: a case-control study. J Clin Immunol. 2013;33:742-747.
Schwitzguébel AJ-P, Jandus P, Lacroix J-S, Seebach JD, Harr T. Immunoglobulin deficiency in patients with chronic rhinosinusitis: systematic review of the literature and meta-analysis. J Allergy Clin Immunol. 2015;136:1523-1531.
Perez E, Bonilla FA, Orange JS, Ballow M. Specific antibody deficiency: controversies in diagnosis and management. Front Immunol. 2017;8:586.
Carr TF, Koterba AP, Chandra R, et al. Characterization of specific antibody deficiency in adults with medically refractory chronic rhinosinusitis. Am J Rhinol Allergy. 2011;25:241-244.
Odat H, Alqudah M. Prevalence and pattern of humoral immunodeficiency in chronic refractory sinusitis. Eur Arch Otorhinolaryngol. 2016;273:3189-3193.
Alqudah M, Graham SM, Ballas ZK. High prevalence of humoral immunodeficiency patients with refractory chronic rhinosinusitis. Am J Rhinol Allergy. 2010;24:409-412.
Miziara ID, Araujo Filho BC, La Cortina RC, et al. Chronic rhinosinusitis in HIV-infected patients: radiological and clinical evaluation. Braz J Otorhinolaryngol. 2005;71:604-608.
Porter JP, Patel AA, Dewey CM, Stewart MG. Prevalence of sinonasal symptoms in patients with HIV infection. Am J Rhinol Allergy. 1999;13:203-208.
García-Rodríguez JF, Corominas M, Fernández-Viladrich P, et al. Rhinosinusitis and atopy in patients infected with HIV. Laryngoscope. 1999;109:939-944.
Baker TM, Satlin MJ. The growing threat of multidrug-resistant gram-negative infections in patients with hematologic malignancies. Leuk Lymphoma. 2016;57:2245-2258.
Sonis ST. The pathobiology of oral mucositis. In: Sonis ST, eds. Oral Mucositis. Tattenhall, UK: Springer Healthcare; 2012:7-13.
Moeller CW, Martin J, Welch KC. Sinonasal evaluation preceding hematopoietic transplantation. Otolaryngol Head Neck Surg. 2011;144:796-801.
Sekine L, Manica D, Piltcher OB, et al. Rhinosinusitis in autologous and allogeneic bone marrow transplantation: a retrospective study on the performance of imaging studies on severity and prognostic evaluation. Rev Bras Hematol Hemoter. 2010;32:29-33.
Dhong HJ, Lee JC, Ryu JS, et al. Rhinosinusitis in transplant patients. Clin Otolaryngol Allied Sci. 2001;26:329-333.
Bento LR, Ortiz E, Nicola EMD, Vigorito AC, Sakano E. Sinonasal disorders in hematopoietic stem cell transplantation. Braz J Otorhinolaryngol. 2014;80:285-289.
Won YW, Yi SY, Jang JH, et al. Retrospective analysis of paranasal sinusitis in patients receiving hematopoietic stem cell transplantation. Int J Hematol. 2011;93:383-388.
Savage DG, Taylor P, Blackwell J, et al. Paranasal sinusitis following allogeneic bone marrow transplant. Bone Marrow Transplant. 1997;19:55-59.
Chinen J, Shearer WT. Secondary immunodeficiencies, including HIV infection. J Allergy Clin Immunol. 2010;125(2 Suppl 2):S195-S203.
Papagiannopoulos P, Kuhar HN, Raman A, et al. Understanding the propensity for chronic sinusitis in patients on immunosuppressive therapy. Am J Rhinol Allergy. 2018;32:478-484.
Zhang Z, Adappa ND, Lautenbach E, et al. The effect of diabetes mellitus on chronic rhinosinusitis and sinus surgery outcome. Int Forum Allergy Rhinol. 2014;4:315-320.
Ouzzani M, Hammady H, Fedorowicz Z, Elmagarmid A. Rayyan-a web and mobile app for systematic reviews. Syst Rev. 2016;5:210.
Centre for Evidence-Based Medicine (CEBM). OCEBM Levels of Evidence. Oxford, UK: Centre for Evidence-Based Medicine; 2016. https://www.cebm.net/2016/05/ocebm-levels-of-evidence/. Accessed July 3, 2020.
Miglani A, Divekar RD, Azar A, et al. Revision endoscopic sinus surgery rates by chronic rhinosinusitis subtype. Int Forum Allergy Rhinol. 2018;8:1047-1051.
Walsh JE, Gurrola JG 2nd, Graham SM, et al. Immunoglobulin replacement therapy reduces chronic rhinosinusitis in patients with antibody deficiency. Int Forum Allergy Rhinol. 2017;7:30-36.
Dao AM, Rereddy SK, Wise SK, et al. Management of non-invasive rhinosinusitis in the immunosuppressed patient population. Laryngoscope. 2015;125:1767-1771.
Benninger MS, Ferguson BJ, Hadley JA, et al. Adult chronic rhinosinusitis: definitions, diagnosis, epidemiology, and pathophysiology. Otolaryngol Head Neck Surg. 2003;129(3 Suppl):S1-S32.
Murphy C, Davidson TM, Jellison W, et al. Sinonasal disease and olfactory impairment in HIV disease: endoscopic sinus surgery and outcome measures. Laryngoscope. 2000;110(10 Pt 1):1707-1710.
Friedman M, Landsberg R, Tanyeri H, et al. Endoscopic sinus surgery in patients infected with HIV. Laryngoscope. 2000;110(10 Pt 1):1613-1616.
Sabini P, Josephson GD, Reisacher WR, Pincus R. The role of endoscopic sinus surgery in patients with acquired immune deficiency syndrome. Am J Otolaryngol. 1998;19:351-356.
Del Borgo C, Del Forno A, Ottaviani F, Fantoni M. Sinusitis in HIV-infected patients. J Chemother. 1997;9:83-88.
Lund VJ, MacKay IS. Outcome assessment of endoscopic sinus surgery. J R Soc Med. 1994;87:70-72.
Wawrose SF, Tami TA, Amoils CP. The role of guaifenesin in the treatment of sinonasal disease in patients infected with the human immunodeficiency virus (HIV). Laryngoscope. 1992;102:1225-1228.
Williams P, White A, Wilson JA, Yap PL. Penetration of administered IgG into the maxillary sinus and long-term clinical effects of intravenous immunoglobulin replacement therapy on sinusitis in primary hypogammaglobulinaemia. Acta Otolaryngol. 1991;111:550-555.
Tas M, Leezenberg JA, Drexhage HA. Beneficial effects of the thymic hormone preparation thymoxtimulin in patients with defects in cell-mediated immunity and chronic purulent rhinosinusitis. A double-blind cross-over trial on improvements in monocyte polarization and clinical effects. Clin Exp Immunol. 2008;80:304-313.
Klimek L, Chaker A, Matthias C, et al. Immunodeficiency in chronic rhinosinusitis: an important and often underestimated cause. HNO. 2019;67:715-730.
Mazza JM, Lin SY. Primary immunodeficiency and recalcitrant chronic sinusitis: a systematic review. Int Forum Allergy Rhinol. 2016;6:1029-1033.
Chiarella SE, Grammer LC. Immune deficiency in chronic rhinosinusitis: screening and treatment. Expert Rev Clin Immunol. 2017;13:117-123.
Leonard CG, Masih C, McDonald S, Taylor G, Maiden N, Leyden PJ. Anti-tumour necrosis factor therapy is associated with certain subtypes of chronic rhinosinusitis. J Laryngol Otol. 2016;130:560-564.
Stewart MG, Johnson RF. Chronic sinusitis: symptoms versus CT scan findings. Curr Opin Otolaryngol Head Neck Surg. 2004;12:27-29.
O'Donnell JG, Sorbello AF, Condoluci DV, Barnish MJ. Sinusitis due to Pseudomonas aeruginosa in patients with human immunodeficiency virus infection. Clin Infect Dis. 1993;16:404-406.
Fried MP, Kelly JH, Strome M. Pseudomonas rhinosinusitis. Laryngoscope. 1984;94(2 Pt 1):192-196.
Marks SC, Upadhyay S, Crane L. Cytomegalovirus sinusitis. A new manifestation of AIDS. Arch Otolaryngol Head Neck Surg. 1996;122:789-791.
Milgrim LM, Rubin JS, Rosenstreich DL, Small CB. Sinusitis in human immunodeficiency virus infection: typical and atypical organisms. J Otolaryngol. 1994;23:450-453.
Tarp B, Kelsen J, Nielsen LP, et al. Herpesvirus type 1-8 in sinus aspirates from HIV-infected patients and immunocompetent individuals. Rhinology. 2001;39:98-102.
Wolf E, Milazzo S, Boehm K, Zwahlen M, Horneber M. Thymic peptides for treatment of cancer patients. Cochrane Database Syst Rev. 2011;2011:CD003993.
Dalm VA, Virgil AS, de Wit H, Drexhage HA. Thymosin α1: a novel therapeutic option for patients with refractory chronic purulent rhinosinusitis. Ann NY Acad Sci. 2012;1270:1-7.